6-1390143-G-A

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001452.2(FOXF2):​c.196G>A​(p.Ala66Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000234 in 1,455,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

FOXF2
NM_001452.2 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 1.36
Variant links:
Genes affected
FOXF2 (HGNC:3810): (forkhead box F2) FOXF2 encodes forkhead box F2, one of many human homologues of the Drosophila melanogaster transcription factor forkhead. FOXF2 is expressed in lung and placenta, and has been shown to transcriptionally activate several lung-specific genes. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12593555).
BS2
High AC in GnomAdExome4 at 33 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FOXF2NM_001452.2 linkuse as main transcriptc.196G>A p.Ala66Thr missense_variant 1/2 ENST00000645481.2 NP_001443.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FOXF2ENST00000645481.2 linkuse as main transcriptc.196G>A p.Ala66Thr missense_variant 1/2 NM_001452.2 ENSP00000496415 P1

Frequencies

GnomAD3 genomes
AF:
0.00000660
AC:
1
AN:
151450
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000301
AC:
3
AN:
99624
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
55902
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000538
Gnomad OTH exome
AF:
0.000353
GnomAD4 exome
AF:
0.0000253
AC:
33
AN:
1304066
Hom.:
0
Cov.:
23
AF XY:
0.0000202
AC XY:
13
AN XY:
644652
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000293
Gnomad4 OTH exome
AF:
0.0000557
GnomAD4 genome
AF:
0.00000660
AC:
1
AN:
151450
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
73944
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 12, 2024The c.196G>A (p.A66T) alteration is located in exon 1 (coding exon 1) of the FOXF2 gene. This alteration results from a G to A substitution at nucleotide position 196, causing the alanine (A) at amino acid position 66 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
FOXF2-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 28, 2024The FOXF2 c.196G>A variant is predicted to result in the amino acid substitution p.Ala66Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0054% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.0098
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.032
T;T
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.40
N
LIST_S2
Benign
0.43
.;T
M_CAP
Pathogenic
0.52
D
MetaRNN
Benign
0.13
T;T
MetaSVM
Benign
-0.61
T
MutationAssessor
Benign
0.34
N;N
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
0.19
.;N
REVEL
Benign
0.17
Sift
Benign
0.44
.;T
Sift4G
Benign
0.83
.;T
Polyphen
0.030
B;B
Vest4
0.072
MutPred
0.28
Gain of glycosylation at A66 (P = 0.0046);Gain of glycosylation at A66 (P = 0.0046);
MVP
0.89
ClinPred
0.050
T
GERP RS
2.1
Varity_R
0.057
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1423083000; hg19: chr6-1390378; API